Xinghui Chen

2.7k total citations
18 papers, 825 citations indexed

About

Xinghui Chen is a scholar working on Infectious Diseases, Health and Modeling and Simulation. According to data from OpenAlex, Xinghui Chen has authored 18 papers receiving a total of 825 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 5 papers in Health and 5 papers in Modeling and Simulation. Recurrent topics in Xinghui Chen's work include SARS-CoV-2 and COVID-19 Research (10 papers), COVID-19 Clinical Research Studies (6 papers) and COVID-19 epidemiological studies (5 papers). Xinghui Chen is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (10 papers), COVID-19 Clinical Research Studies (6 papers) and COVID-19 epidemiological studies (5 papers). Xinghui Chen collaborates with scholars based in China, United States and Switzerland. Xinghui Chen's co-authors include Hongjie Yu, Qianhui Wu, Cécile Viboud, Marco Ajelli, Juan Yang, Kaige Dong, Xufang Bai, Tingyu Zhuang, Daniel A. Salmon and Matthew Z. Dudley and has published in prestigious journals such as Science, SHILAP Revista de lepidopterología and Clinical Infectious Diseases.

In The Last Decade

Xinghui Chen

17 papers receiving 815 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xinghui Chen China 11 582 373 243 99 62 18 825
Gregory Barnsley United Kingdom 6 574 1.0× 266 0.7× 332 1.4× 101 1.0× 50 0.8× 8 922
Timothy B. Frankland United States 12 899 1.5× 237 0.6× 427 1.8× 192 1.9× 36 0.6× 36 1.2k
Megan O’Driscoll United Kingdom 9 483 0.8× 298 0.8× 107 0.4× 147 1.5× 75 1.2× 18 880
Yeheskel Levy Israel 7 961 1.7× 335 0.9× 531 2.2× 89 0.9× 52 0.8× 11 1.2k
Molly Steele United States 11 566 1.0× 324 0.9× 109 0.4× 130 1.3× 112 1.8× 19 926
Omesh N. Ranasinghe United States 7 649 1.1× 198 0.5× 331 1.4× 53 0.5× 33 0.5× 9 807
Ruijia Sun China 9 446 0.8× 217 0.6× 98 0.4× 73 0.7× 35 0.6× 12 620
Bingyi Yang Hong Kong 16 1.0k 1.7× 295 0.8× 152 0.6× 181 1.8× 38 0.6× 51 1.4k
Cécile Tran Kiem France 11 488 0.8× 491 1.3× 105 0.4× 138 1.4× 94 1.5× 20 889
Omri Bodenheimer Israel 7 938 1.6× 259 0.7× 401 1.7× 63 0.6× 39 0.6× 10 1.1k

Countries citing papers authored by Xinghui Chen

Since Specialization
Citations

This map shows the geographic impact of Xinghui Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinghui Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinghui Chen more than expected).

Fields of papers citing papers by Xinghui Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinghui Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinghui Chen. The network helps show where Xinghui Chen may publish in the future.

Co-authorship network of co-authors of Xinghui Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Xinghui Chen. A scholar is included among the top collaborators of Xinghui Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinghui Chen. Xinghui Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Ge, Shuang, Rong Liu, Liping Sun, et al.. (2025). Ultraviolet-treated riboflavin alleviates atopic dermatitis by inhibiting NLRP3 inflammasome activation and M1 macrophage polarization via histone lactylation. Biochemical Pharmacology. 236. 116879–116879. 1 indexed citations
3.
Chen, Xinghui, Shuang Ge, Yulin Liu, et al.. (2024). UV-stimulated riboflavin exerts immunosuppressive effects in BALB/c mice and human PBMCs. Biomedicine & Pharmacotherapy. 173. 116278–116278. 1 indexed citations
4.
Hu, Xinghua, et al.. (2023). Optimization model for bus priority control considering carbon emissions under non-bus lane conditions. Journal of Cleaner Production. 402. 136747–136747. 10 indexed citations
5.
Chen, Xinghui, et al.. (2023). Simulation of Temperature Field in FSW of 6061T6 Aluminum Alloy IGBT Liquid Cooled Radiator Panel. Journal of Physics Conference Series. 2468(1). 12053–12053. 1 indexed citations
6.
Chen, Xinhua, Xinghui Chen, Nan Zheng, et al.. (2023). Modeling the Prediction on the Efficacy of a Homologous Third Dose of CoronaVac Against SARS-CoV-2 Omicron BA.1, BA.2, BA.2.12.1, and BA.4/5 — China, 2020–2021. China CDC Weekly. 5(5). 103–107. 2 indexed citations
8.
Chen, Zhiyuan, Wen Zheng, Qianhui Wu, et al.. (2022). Global diversity of policy, coverage, and demand of COVID-19 vaccines: a descriptive study. BMC Medicine. 20(1). 130–130. 27 indexed citations
9.
Liu, Hengcong, Juanjuan Zhang, Jun Cai, et al.. (2022). Investigating vaccine-induced immunity and its effect in mitigating SARS-CoV-2 epidemics in China. BMC Medicine. 20(1). 37–37. 12 indexed citations
10.
Hu, Xinghua, et al.. (2022). Road Traffic Status Prediction Approach Based on Kmeans-Decision Tree Model. SHILAP Revista de lepidopterología. 12(2). 108–115. 4 indexed citations
11.
Chen, Xinghui, Wei Wang, Ying Qin, Junyi Zou, & Hongjie Yu. (2022). Global Epidemiology of Human Infections With Variant Influenza Viruses, 1959–2021: A Descriptive Study. Clinical Infectious Diseases. 75(8). 1315–1323. 8 indexed citations
12.
Chen, Xinhua, Zhiyuan Chen, Andrew S. Azman, et al.. (2021). Neutralizing Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants Induced by Natural Infection or Vaccination: A Systematic Review and Pooled Analysis. Clinical Infectious Diseases. 74(4). 734–742. 67 indexed citations
13.
Chen, Xinhua, Zhiyuan Chen, Andrew S. Azman, et al.. (2021). Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis. The Lancet Global Health. 9(5). e598–e609. 126 indexed citations
14.
Wu, Qianhui, Matthew Z. Dudley, Xinghui Chen, et al.. (2021). Evaluation of the safety profile of COVID-19 vaccines: a rapid review. BMC Medicine. 19(1). 173–173. 148 indexed citations
15.
Chen, Xinhua, Zhiyuan Chen, Andrew S. Azman, et al.. (2021). Neutralizing Antibodies Against SARS-CoV-2 Variants Induced by Natural Infection or Vaccination: A Systematic Review and Individual Data Meta-Analysis. SSRN Electronic Journal. 10 indexed citations
16.
Sun, Kaiyuan, Wei Wang, Lidong Gao, et al.. (2020). Transmission heterogeneities, kinetics, and controllability of SARS-CoV-2. Science. 371(6526). 243 indexed citations
17.
Wang, Wei, Qianhui Wu, Juan Yang, et al.. (2020). Global, regional, and national estimates of target population sizes for covid-19 vaccination: descriptive study. BMJ. 371. m4704–m4704. 128 indexed citations
18.
Chen, Zhiyuan, Andrew S. Azman, Xiaowei Deng, et al.. (2020). Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis. medRxiv. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026